Millipore Sigma Vibrant Logo

401020 Imiquimod - CAS 99011-02-6 - Calbiochem

An imidazoquinoline compound that acts as a potent immunomodulator and displays anti-angiogenic, anti-viral and anti-inflammatory properties.

Imiquimod - CAS 99011-02-6 - Calbiochem : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: 1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine

Primary Target: TLR7 (toll-like receptor 7)
View Products on Sigmaaldrich.com
401020
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
99011-02-6C₁₄H₁₆N₄

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
401020-250MG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 250 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewAn imidazoquinoline compound that acts as a potent immunomodulator and displays anti-angiogenic, anti-viral and anti-inflammatory properties. Reported to bind to the cell surface receptor, TLR7 (toll-like receptor 7), and induce the secretion of several pro-inflammatory cytokines and chemokines both in vitro and in vivo.
      Catalogue Number401020
      Brand Family Calbiochem®
      Synonyms1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine
      References
      ReferencesMajewski, S., et al. 2005. Int. J. Dermatol. 44, 14.
      Gibson, S.J., et al. 2002. Cell. Immunol. 218, 74.
      Hemmi, H., et al. 2002. Nat. Immunol. 3, 196.
      Megyeri, K., et al. 1995. Mol. Cell. Biol. 15, 2207.
      Product Information
      CAS number99011-02-6
      ATP CompetitiveN
      FormWhite solid
      Hill FormulaC₁₄H₁₆N₄
      Chemical formulaC₁₄H₁₆N₄
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetTLR7 (toll-like receptor 7)
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 25-36/37/38

      Toxic if swallowed.
      Irritating to eyes, respiratory system and skin.
      S PhraseS: 26-45

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Toxic
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. Upon thawing, warming may be required to resolubilize precipitated product.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      401020-250MG 04055977189414

      Documentation

      Imiquimod - CAS 99011-02-6 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Imiquimod - CAS 99011-02-6 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      401020

      Références bibliographiques

      Aperçu de la référence bibliographique
      Majewski, S., et al. 2005. Int. J. Dermatol. 44, 14.
      Gibson, S.J., et al. 2002. Cell. Immunol. 218, 74.
      Hemmi, H., et al. 2002. Nat. Immunol. 3, 196.
      Megyeri, K., et al. 1995. Mol. Cell. Biol. 15, 2207.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision05-May-2009 JSW
      Synonyms1-(2-Methylpropyl)-1H-imidazole[4,5-c]quinoline-4-amine
      DescriptionAn imidazoquinoline compound that acts as a potent immunomodulator and displays anti-angiogenic, anti-viral and anti-inflammatory properties. Reported to bind to the cell surface receptor, TLR7 (toll-like receptor 7), and induce the secretion of several pro-inflammatory cytokines and chemokines both in vitro and in vivo.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number99011-02-6
      Chemical formulaC₁₄H₁₆N₄
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (3 mg/ml); warming to 60°C is required for complete solubilization.
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. Upon thawing, warming may be required to resolubilize precipitated product.
      Toxicity Toxic
      ReferencesMajewski, S., et al. 2005. Int. J. Dermatol. 44, 14.
      Gibson, S.J., et al. 2002. Cell. Immunol. 218, 74.
      Hemmi, H., et al. 2002. Nat. Immunol. 3, 196.
      Megyeri, K., et al. 1995. Mol. Cell. Biol. 15, 2207.